
Opinion|Videos|September 19, 2024
Improved Quality of Life: Upadacitinib's Role in Managing AD
Key opinion leaders examine upadacitinib's role in managing atopic dermatitis and its impact on improving patients' quality of life.
Advertisement
Episodes in this series

Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
2
Comparative Analysis Positions Zasocitinib Among Next-Generation TYK2 Inhibitors
3
Alpha Tau Submits First PMA Module to FDA for Novel cSCC Treatment, Alpha DaRT
4
Journal Digest: January 14, 2026
5
















